Drug Shortage Report for APO-GLICLAZIDE
Report ID | 26159 |
Drug Identification Number | 02245247 |
Brand name | APO-GLICLAZIDE |
Common or Proper name | GLICLAZIDE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | GLICLAZIDE |
Strength(s) | 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 BTL & 500 BTL |
ATC code | A10BB |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-10-16 |
Estimated end date | 2018-06-22 |
Actual end date | 2018-05-21 |
Shortage status | Resolved |
Updated date | 2018-05-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.